Clinical Trial Update: Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation

View source ↗

Summary

A tissue study is being conducted to investigate chronic active humoral rejection in kidney transplant recipients; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Active Humoral Rejection

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Kidney Transplant | Status: RECRUITING